Dermavant Sciences' first consumer TV ad for its Vtama psoriasis med shows people ready for a new topical treatment.
November 23, 2022 01:35 PM ESTUpdated 03:16 PM
Pharma
Marketing

Roivant’s Der­ma­vant de­buts first-ever TV com­mer­cial for pso­ri­a­sis cream Vta­ma

Beth Snyder Bulik

Senior Editor

Der­ma­vant Sci­ences has been mar­ket­ing its first prod­uct, pso­ri­a­sis med Vta­ma, to der­ma­tol­o­gists for months, but on Tues­day it rolled out its first con­sumer cam­paign …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times